NANCY BRESLIN: Open Payments
NPI 1871733808 · NEW ALBANY, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$821 in 7 payments from 7 companies in 2025. Trend: 2023 $540 · 2024 $178 · 2025 $821
Food & beverage: $821
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 1 | $125 |
| ADC THERAPEUTICS AMERICA, INC. | 1 | $122 |
| Daiichi Sankyo Inc. | 1 | $120 |
| AstraZeneca Pharmaceuticals LP | 1 | $120 |
| JAZZ PHARMACEUTICALS INC. | 1 | $120 |
| Iovance Biotherapeutics, Inc. | 1 | $114 |
| GENZYME CORPORATION | 1 | $101 |
Products named: VENCLEXTA, ZYNLONTA, Vanflyta, IMFINZI, ZEPZELCA, Amtagvi, WAYRILZ.
Industry payments across IN — which companies pay providers there.
